Ermina Stratina

Iasi, IS, Romania

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania.

Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania.

Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: August 29, 2026

MASLD or MetALD? Unveiling the Role of Alcohol in Liver Disease Progression in Diabetic Patients.

MASLD or MetALD? Unveiling the Role of Alcohol in Liver Disease Progression in Diabetic Patients.

Journal: Biomedicines
Published: December 09, 2025

Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Bile Duct Stones-Avoiding the Avoidable.

Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Bile Duct Stones-Avoiding the Avoidable.

Journal: Biomedicines
Published: December 07, 2025

Prevalence and Risk Factors for Hepatitis C Virus Infection in Vulnerable Populations in Romania: A Population-based Screening from the LIVE(RO)2 Program.

Prevalence and Risk Factors for Hepatitis C Virus Infection in Vulnerable Populations in Romania: A Population-based Screening from the LIVE(RO)2 Program.

Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: September 07, 2025

Beyond BMI: revealing metabolic risk in lean MASLD.

Beyond BMI: revealing metabolic risk in lean MASLD.

Journal: Archive of clinical cases
Published: August 05, 2025

Reply to Scarlata, G.G.M.; Abenavoli, L. Comment on "Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis. Life 2025, 15, 288".

Reply to Scarlata, G.G.M.; Abenavoli, L. Comment on "Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis. Life 2025, 15, 288".

Journal: Life (Basel, Switzerland)
Published: July 02, 2025

Screening of advanced fibrosis and metabolic dysfunction-associated steatotic liver disease using transient elastography in vulnerable population.

Screening of advanced fibrosis and metabolic dysfunction-associated steatotic liver disease using transient elastography in vulnerable population.

Journal: Scientific reports
Published: February 24, 2025

Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis.

Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis.

Journal: Life (Basel, Switzerland)
Published: January 17, 2025

Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response.

Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response.

Journal: Medicina (Kaunas, Lithuania)
Published: August 09, 2024

New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Diagnostics (Basel, Switzerland)
Published: June 11, 2024

The Impact of Alcohol Consumption Pattern on Liver Fibrosis in Asymptomatic Patients.

The Impact of Alcohol Consumption Pattern on Liver Fibrosis in Asymptomatic Patients.

Journal: Journal of clinical medicine
Published: November 02, 2023

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy-A New Potential Therapeutic Target in Inflammatory Bowel Disease.

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy-A New Potential Therapeutic Target in Inflammatory Bowel Disease.

Journal: Diagnostics (Basel, Switzerland)
Published: February 27, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026